A Novel Treatment for Vascular Calcification in Patients With Dialysis-Dependent Chronic Kidney Disease

Slowing Progression of Cardiovascular Calcification with SNF472 in Patients on Hemodialysis: Results of a Randomized, Phase 2b Study

(2019) Paolo Raggi et al.   CIRCULATION

Management of Traditional Cardiovascular Risk Factors in CKD: What Are the Data?

(2018) L. Parker Gregg et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Diagnosis and management of atherosclerotic cardiovascular disease in chronic kidney disease: a review

(2017) Roy O. Mathew et al.   KIDNEY INTERNATIONAL

Effect Modification of Chronic Kidney Disease on the Association of Circulating and Imaging Cardiac Biomarkers With Outcomes

(2017) L. Parker Gregg et al.   Journal of the American Heart Association

Sevelamer Versus Calcium-Based Binders for Treatment of Hyperphosphatemia in CKD: A Meta-Analysis of Randomized Controlled Trials

(2015) L. Patel et al.   Clinical Journal of the American Society of Nephrology

Con: Vascular calcification is a surrogate marker, but not the cause of ongoing vascular disease, and it is not a treatment target in chronic kidney disease

(2015) C. Zoccali et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Evaluation of Aortic Calcification With Lanthanum Carbonate vs. Calcium-Based Phosphate Binders in Maintenance Hemodialysis Patients With Type 2 Diabetes Mellitus: An Open-Label Randomized Controlled Trial

(2014) Kentaro Wada et al.   THERAPEUTIC APHERESIS AND DIALYSIS

Mortality in Kidney Disease Patients Treated with Phosphate Binders: A Randomized Study

(2012) B. Di Iorio et al.   Clinical Journal of the American Society of Nephrology

The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis

(2010) P. Raggi et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION